4//SEC Filing
TICHENOR MCHENRY T 4
Accession 0001209191-19-024202
CIK 0001426332other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 11:26 AM ET
Size
12.5 KB
Accession
0001209191-19-024202
Insider Transaction Report
Form 4
TICHENOR MCHENRY T
Director
Transactions
- Conversion
Common Stock
2019-04-08+1,833,332→ 1,872,314 total(indirect: See Footnote) - Conversion
Series C Convertible Preferred Stock
2019-04-08−166,666→ 0 total(indirect: See Footnote)→ Common Stock (166,666 underlying) - Conversion
Series B Convertible Preferred Stock
2019-04-08−1,616,666→ 0 total(indirect: See Footnote)→ Common Stock (1,616,666 underlying) - Conversion
Series D Convertible Preferred Stock
2019-04-08−50,000→ 0 total(indirect: See Footnote)→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]Every two shares of Series B preferred stock, Series C preferred stock and Series D preferred stock automatically converted into one share of common stock in connection with the closing of the issuer's initial public offering. These shares have no expiration date.
- [F2]The Reporting Person, a Director of the Issuer, is the President and managing partner of Tichenor Ventures, LLC and has sole voting and investment power with respect to such shares.
- [F3]The shares are beneficially owned by Tichenor Ventures, LLC
Documents
Issuer
NGM BIOPHARMACEUTICALS INC
CIK 0001426332
Entity typeother
Related Parties
1- filerCIK 0001034497
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 11:26 AM ET
- Size
- 12.5 KB